Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.05 (11.76%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £2.15m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Issue of Equity

6 Apr 2011 07:00

RNS Number : 3520E
Physiomics PLC
06 April 2011
 



 

Physiomics plc

("Physiomics" or the "Company")

 

Completion of Placing

 

The Company announces that it has raised £600,000 from the issue of 120,000,000 new ordinary shares of 0.04p each ("Ordinary Shares") at a price of 0.5p per share, by way of a placing through WH Ireland Limited (the "Placing"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 12 April 2011.

 

Following the Placing, the number of Ordinary Shares in issue will increase to 1,122,150,074 ordinary shares.

 

The funds raised from the Placing will be used for working capital purposes.

 

For the purposes of the Financial Services Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consisted of 1,122,150,074 Shares with voting rights attached (one vote per Share). There are no Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Physiomics under the DTRs.

 

Enquiries:

 

Physiomics plc

Mark Chadwick

+44 (0)1865 784980

 

WH Ireland Limited

Katy Mitchell

+44 (0) 161 832 2174

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEALLSEANFEFF
Date   Source Headline
23rd Feb 20227:00 amRNSBoard Changes
21st Feb 202210:00 amRNSDoseMeRx Update
19th Jan 202212:30 pmRNSIssue of Equity
22nd Dec 202112:00 pmRNSContract award
13th Dec 20217:00 amRNSMerck Contracts
23rd Nov 20213:30 pmRNSResult of AGM
12th Nov 202112:00 pmRNSConference presentation
12th Nov 202112:00 pmRNSConference presentation
27th Oct 20211:00 pmRNSPosting of Annual Report and AGM Notice
22nd Oct 20217:00 amRNSContract awards
30th Sep 20213:00 pmRNSResults Presentation and DoseMeRx Update
30th Sep 20217:00 amRNSFinal Results
16th Sep 20212:45 pmRNSPARNTER study recruits first patient
15th Sep 20217:00 amRNSNotice of Results and Investor Presentation
31st Aug 20217:00 amRNSPhysiomics hires Head of Business Development
19th Jul 20217:00 amRNSPhysiomics expands technical team
29th Jun 20219:16 amRNSDirector Dealing
21st May 20214:40 pmRNSDirector Dealing
21st May 20217:00 amRNSContract awards
14th May 20217:00 amRNSContract award
11th May 20217:00 amRNSContract award
10th May 20217:00 amRNSTrading update
9th Apr 20212:00 pmRNSConference presentation
22nd Mar 20217:00 amRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSPresentation and Q&A on Company's Interim Results
4th Mar 20217:00 amRNSInterim Results Presentation
2nd Mar 202110:12 amRNSIssue of Options
1st Mar 20217:00 amRNSInterim Results
15th Feb 20217:00 amRNSValiRx Agreement
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20202:00 pmRNSPartnership with TRHC's DoseMeRx®
17th Dec 20207:00 amRNSMerck Contracts
14th Dec 20207:00 amRNSApproval of NIHR-funded PARTNER study
17th Nov 202012:59 pmRNSResult of AGM
22nd Oct 20208:30 amRNSPosting of Annual Report and AGM Notice
22nd Oct 20207:00 amRNSPosting of Annual Report and AGM Notice
16th Oct 20207:00 amRNSContract awards
6th Oct 20209:00 amRNSPresentation and Q&A on Company’s Final Results
30th Sep 20207:00 amRNSFinal Results and Notice of AGM
25th Sep 20207:00 amRNSFull year results release date and shareholder Q&A
11th Sep 20207:00 amRNSHolding(s) in Company
12th Aug 20207:00 amRNSDirector Dealing
5th Aug 20201:00 pmRNSIssue of Equity
5th Aug 20207:00 amRNSIssue of Equity and Director Dealing
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSPhysiomics awarded contract by Astellas Pharma Inc
22nd Jul 202011:45 amRNSShare Price Movement
17th Jul 20209:00 amRNSPrice Monitoring Extension
6th Jul 202010:00 amRNSDirector dealing
30th Jun 20202:30 pmRNSContract award and update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.